Ana Oaknin

发表

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Gabe S. Sonke, Anne Floquet, Kathleen Moore, 2018, The New England journal of medicine.

Improved survival with bevacizumab in advanced cervical cancer.

Michael W Sill, Helen Huang, B. Monk, 2014, The New England journal of medicine.

Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.

Ignace Vergote, Beth Y Karlan, Christian Marth, 2016, Gynecologic oncology.

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

Anne Floquet, Andrew R Allen, James X. Sun, 2017, The Lancet. Oncology.